Clinical Trial Update: An Open, Single Center, Non-randomized, Single Arm Clinical Study of Evaluating the Efficacy of Selinexor in the Maintenance Treatment of PTCL [Phase 2, Phase 3]

View source ↗

Summary

Open-label, single-center, non-randomized study evaluating selinexor as maintenance therapy in patients with peripheral T-cell lymphoma who achieved complete re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• Selinexor (selinexor)

Snippet

Sponsor: The First Hospital of Jilin University | Conditions: PTCL Patients Who Achieved Complete Response From Frontline Treatment | Phase 2, Phase 3 | Status: UNKNOWN